AGL 38.50 Increased By ▲ 0.93 (2.48%)
AIRLINK 131.81 Decreased By ▼ -0.69 (-0.52%)
BOP 5.59 Decreased By ▼ -0.05 (-0.89%)
CNERGY 3.84 Increased By ▲ 0.07 (1.86%)
DCL 8.67 Decreased By ▼ -0.20 (-2.25%)
DFML 40.80 Decreased By ▼ -0.20 (-0.49%)
DGKC 88.71 Decreased By ▼ -1.45 (-1.61%)
FCCL 35.24 Increased By ▲ 0.16 (0.46%)
FFBL 66.49 Decreased By ▼ -0.01 (-0.02%)
FFL 10.46 Increased By ▲ 0.31 (3.05%)
HUBC 109.50 Increased By ▲ 3.10 (2.91%)
HUMNL 14.66 Increased By ▲ 1.26 (9.4%)
KEL 4.81 Decreased By ▼ -0.05 (-1.03%)
KOSM 7.07 Increased By ▲ 0.22 (3.21%)
MLCF 42.50 Increased By ▲ 0.70 (1.67%)
NBP 59.49 Increased By ▲ 0.91 (1.55%)
OGDC 183.94 Increased By ▲ 2.69 (1.48%)
PAEL 25.56 Decreased By ▼ -0.14 (-0.54%)
PIBTL 5.90 Increased By ▲ 0.07 (1.2%)
PPL 147.50 Decreased By ▼ -0.90 (-0.61%)
PRL 23.55 Increased By ▲ 0.33 (1.42%)
PTC 16.45 Increased By ▲ 1.21 (7.94%)
SEARL 69.23 Increased By ▲ 0.44 (0.64%)
TELE 7.22 Decreased By ▼ -0.02 (-0.28%)
TOMCL 35.77 Decreased By ▼ -0.23 (-0.64%)
TPLP 7.55 Increased By ▲ 0.15 (2.03%)
TREET 14.20 Decreased By ▼ -0.04 (-0.28%)
TRG 50.85 No Change ▼ 0.00 (0%)
UNITY 26.83 Increased By ▲ 0.43 (1.63%)
WTL 1.22 Increased By ▲ 0.01 (0.83%)
BR100 9,813 Increased By 45.5 (0.47%)
BR30 29,780 Increased By 379.7 (1.29%)
KSE100 92,374 Increased By 436.2 (0.47%)
KSE30 28,829 Increased By 85.2 (0.3%)

Karachi: The Drug Regulatory Authority of Pakistan (DRAP) in Wednesday agreed to increase price of Paracetamol tablets from Rs. 1.90 per tablet to Rs 2.65 per tablet, sources privy to the development told Business Recorder.

In this regard, the sources explained, a summary would be forwarded to federal cabinet for approval. Former chairman Pakistan Pharmaceutical Manufact-urers Association (PPMA) Dr Kaiser Waheed said Paracetamol availability was disturbed for a short period due to non-availability of basic ingredients to manufacture its active raw material

He informed that some of the factories, producing active ingredient of in china, were closed down due to certain reasons. Noteworthy to mention here that, Pakistan is facing extreme shortage of various brands of Paracetamol at the moment amid Covid-19 third wave and growing dengue, typhoid and malaria cases.

Copyright Business Recorder, 2022

Comments

Comments are closed.